Search research articles
Contact Us
Filters
Showing results (71-80 of 165) with videos related to
Page
of 17
Sort By:
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
August 18, 2020
Impact of Clostridioides difficile infection on the outcome of patients receiving a hematopoietic stem cell transplantation
Sarah Weber, Sebastian Scheich, Aaron Magh, et al.
Bone Marrow Transplantation
|
December 9, 2020
Second- and third-generation tyrosine kinase inhibitors for Philadelphia-positive adult acute lymphoblastic leukemia relapsing post allogeneic stem cell transplantation-a registry study on behalf of the EBMT Acute Leukemia Working Party
Klaus Hirschbühl, Myriam Labopin, Mohamed Houhou, et al.
Blood
|
April 9, 2005
Early molecular response to posttransplantation imatinib determines outcome in MRD+ Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL)
Barbara Wassmann, Heike Pfeifer, Michael Stadler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 18, 2011
Prognostic significance of ASXL1 mutations in patients with myelodysplastic syndromes
Felicitas Thol, Inna Friesen, Frederik Damm, et al.
Haematologica
|
November 3, 2009
Monitoring of donor chimerism in sorted CD34+ peripheral blood cells allows the sensitive detection of imminent relapse after allogeneic stem cell transplantation
Martin Bornhäuser, Uta Oelschlaegel, Uwe Platzbecker, et al.
Blood
|
March 20, 2013
β2 integrin-derived signals induce cell survival and proliferation of AML blasts by activating a Syk/STAT signaling axis
Thomas Oellerich, Mark F Oellerich, Michael Engelke, et al.
Bone Marrow Transplantation
|
March 31, 2023
Fludarabine/TBI 8 Gy versus fludarabine/treosulfan conditioning in patients with AML in first complete remission: a study from the Acute Leukemia Working Party of the EBMT
Gesine Bug, Myriam Labopin, Riitta Niittyvuopio, et al.
Cancers
|
September 27, 2025
First-in-Human Study of MDG1011, a TCR-T Therapy Directed Against HLA-A*02:01-Restricted PRAME Antigen for High-Risk Myeloid and Lymphoid Neoplasms
Simone Thomas, Martin Wermke, Vladan Vučinić, et al.
Leukemia
|
October 7, 2025
Genetic and epigenetic alterations at secondary resistance after continued decitabine-based treatment of acute myeloid leukemia in the randomized phase II DECIDER trial
Inga Hund, Maria Elena Hess, Geoffroy Andrieux, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 6, 2026
First-in-Human Study of IL15-Activated Cytokine-Induced Killer Cells After Allogeneic HCT Shows Durable Remission and Serotherapy-Associated Immune Reconstitution in Leukemia
Eva Rettinger, Dirk Heckl, Martin Hutter, et al.
Page
of 17
Search research articles
Search
Showing results (71-80 of 165) with videos related to
Sort By:
Page
of 17
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
August 18, 2020
Impact of Clostridioides difficile infection on the outcome of patients receiving a hematopoietic stem cell transplantation
Sarah Weber, Sebastian Scheich, Aaron Magh, et al.
Bone Marrow Transplantation
|
December 9, 2020
Second- and third-generation tyrosine kinase inhibitors for Philadelphia-positive adult acute lymphoblastic leukemia relapsing post allogeneic stem cell transplantation-a registry study on behalf of the EBMT Acute Leukemia Working Party
Klaus Hirschbühl, Myriam Labopin, Mohamed Houhou, et al.
Blood
|
April 9, 2005
Early molecular response to posttransplantation imatinib determines outcome in MRD+ Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL)
Barbara Wassmann, Heike Pfeifer, Michael Stadler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 18, 2011
Prognostic significance of ASXL1 mutations in patients with myelodysplastic syndromes
Felicitas Thol, Inna Friesen, Frederik Damm, et al.
Haematologica
|
November 3, 2009
Monitoring of donor chimerism in sorted CD34+ peripheral blood cells allows the sensitive detection of imminent relapse after allogeneic stem cell transplantation
Martin Bornhäuser, Uta Oelschlaegel, Uwe Platzbecker, et al.
Blood
|
March 20, 2013
β2 integrin-derived signals induce cell survival and proliferation of AML blasts by activating a Syk/STAT signaling axis
Thomas Oellerich, Mark F Oellerich, Michael Engelke, et al.
Bone Marrow Transplantation
|
March 31, 2023
Fludarabine/TBI 8 Gy versus fludarabine/treosulfan conditioning in patients with AML in first complete remission: a study from the Acute Leukemia Working Party of the EBMT
Gesine Bug, Myriam Labopin, Riitta Niittyvuopio, et al.
Cancers
|
September 27, 2025
First-in-Human Study of MDG1011, a TCR-T Therapy Directed Against HLA-A*02:01-Restricted PRAME Antigen for High-Risk Myeloid and Lymphoid Neoplasms
Simone Thomas, Martin Wermke, Vladan Vučinić, et al.
Leukemia
|
October 7, 2025
Genetic and epigenetic alterations at secondary resistance after continued decitabine-based treatment of acute myeloid leukemia in the randomized phase II DECIDER trial
Inga Hund, Maria Elena Hess, Geoffroy Andrieux, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 6, 2026
First-in-Human Study of IL15-Activated Cytokine-Induced Killer Cells After Allogeneic HCT Shows Durable Remission and Serotherapy-Associated Immune Reconstitution in Leukemia
Eva Rettinger, Dirk Heckl, Martin Hutter, et al.
Page
of 17